ED2 Elements of Value for Gene Therapy: A Systematic Review
ISPOR recommends that value assessments include elements beyond traditional quality-adjusted life years (QALYs) and costs. We aimed to identify non-traditional value elements relevant to gene therapies as it is unclear to what extent they have been included in gene therapy value assessments.
Source: Value in Health - Category: International Medicine & Public Health Authors: E. Kim, K. Raimundo, Z.A. Marcum, D.L. Veenstra Source Type: research